Sökresultat

Menneskerettigheder presser Fort Europa - The Raoul Wallenberg Institute of Human Rights and Humanitarian Law Skip to content Search for: Search Button Home About Us Who We Are Our History About Raoul Wallenberg Our Theory of Change Staff Opportunities Annual Reports Whistleblower Our work What we do Multi-Disciplinary Research Higher Education Strategic Advice and Analysis Outreach Evaluation of

https://rwi.lu.se/publications/menneskerettigheder-presser-fort-europa/ - 2026-05-29

Denna kandidatuppsats är en kvalitativ undersökning över hur länder i en rykteskris använder nationsvarumärkning och mjuk makt för att motverka negativa stereoty- per och förbättra sitt globala rykte. Nationsvarumärkning beskrivs som ett strate- giskt verktyg för att förbättra ett lands rykte och attraktivitet genom olika mark- nadsförings- och varumärkesmetoder. Flerstegsmodellen introduceras som

BACKGROUND: Tofacitinib is a Janus kinase inhibitor for the treatment of ulcerative colitis (UC). Prospective real-world data are scarce.OBJECTIVES: To collect data on clinical outcomes, including health-related quality of life (HRQoL) and fatigue during treatment with tofacitinib.DESIGN: This is a prospective observational multicentre study in Sweden. In this analysis, outcomes at weeks 2, 8 and

C-telopeptide of type II collagen (CTX-II) has been shown to be a highly relevant biomarker of cartilage degradation in human rheumatic diseases, if measured in synovial fluid or urine. However, serum or plasma CTX-II have not been demonstrated to have any clinical utility to date. Here, we describe the GPDPLQ1237 ELISA which targets the EKGPDPLQ↓ neo-epitope, an elongated version of the CTX-II neC-telopeptide of type II collagen (CTX-II) has been shown to be a highly relevant biomarker of cartilage degradation in human rheumatic diseases, if measured in synovial fluid or urine. However, serum or plasma CTX-II have not been demonstrated to have any clinical utility to date. Here, we describe the GPDPLQ1237 ELISA which targets the EKGPDPLQ↓ neo-epitope, an elongated version of the CTX-II ne

Familial hemophagocytic lymphohistiocytosis (FHL) is caused by biallelic variants in genes regulating granule secretion in cytotoxic lymphocytes. In FHL3–5, the affected genes UNC13D, STX11 and STXBP2 have further been shown to regulate the secretion of platelet granules, giving rise to compromised platelet function. Therefore, we aimed to investigate platelet degranulation in patients heterozygou

Molybdenum complexes of 3,6-di-tert-butylcatechol have been prepared from the reaction between [Mo(CO)6] and 3,6-di-tert-butyl-1,2-benzoquinone. A putative "[MoO(3,6-DBCat)2]" monomer is assumed to form initially by reaction with trace quantities of oxygen. Condensation of the reaction mixture leads to the formation of oligomeric products, including the [{MoO(3,6-DBCat)2}4] chiral square isolated

Background: Breast cancer is the most common female malignancy and the leading cause of cancer-related deaths worldwide. Targeted therapy against the main biomarkers estrogen receptor alpha (ER) and human epidermal growth factor receptor 2 (HER2/ERBB2) have greatly improved mortality rates, but ab initio or acquired therapy resistance is common. It is imperative to identify patients who will benef

Doktorand Kontaktinformation E-post: serde [dot] atalay [at] jur [dot] lu [dot] se Telefon: +46 46 222 11 75Organisation Juridiska institutionen Rumsnummer: 321 Hämtställe: 56 WebbplatsSerde Atalays profil i Lunds universitets forskningsportalAndra roller Forskare Mänskliga rättigheter Profilområdesmedlem LU profilområde: Mänskliga rättigheter Forskare Folkrätt Forskare Migrationsrätt Publikatione

https://www.jur.lu.se/serde-atalay - 2026-05-29

Ett smartare Sverige Sacos kongress 2025 Verksamhets­ rapport januari–juni 2025 1/14 Uppföljning av verksamheten första halvåret 2025 Sammanfattning Under det första halvåret 2025 har Saco bedrivit aktivt påverkansarbete och mediegenomslaget har varit starkt. Därutöver har nya aktiviteter genomförts för att ytterligare stärka samverkan och stöd inom federationen. Rapporter, remissvar, debattartikl

https://www.saco.se/globalassets/bilder-video-och-dokument/evenemang/kongresser/sacos-kongress-2025/handlingar/verksamhetsrapport-januari-juni-2025.pdf - 2026-05-28

Homelessness has increased significantly in Sweden since the early 1990s. A national surveyof homelessness in 2023 showed that 27,383 people were in one of the four homelessnesssituations that are recognised in Sweden, namely: (a) acute homelessness; (b) institutional orsupported housing; (c) long-term housing organised by a municipality; and (d) short-termaccommodation arranged by people themselv